Rolipram
CAS No. 61413-54-5
Rolipram ( SB95952;ZK62711;(R,S)-Rolipram;SB 95952;ZK 62711;SB-95952;ZK-62711 )
产品货号. M15314 CAS No. 61413-54-5
A potent, selective inhibitor of phosphodiesterases PDE4 with IC50 of 3 nM, 130 nM and 240 nM for PDE4A, PDE4B, and PDE4D, respectively.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
10MG | ¥348 | 有现货 |
|
50MG | ¥494 | 有现货 |
|
100MG | ¥705 | 有现货 |
|
200MG | ¥1037 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Rolipram
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述A potent, selective inhibitor of phosphodiesterases PDE4 with IC50 of 3 nM, 130 nM and 240 nM for PDE4A, PDE4B, and PDE4D, respectively.
-
产品描述A potent, selective inhibitor of phosphodiesterases PDE4 with IC50 of 3 nM, 130 nM and 240 nM for PDE4A, PDE4B, and PDE4D, respectively; increases phosphorylation of CREB in U937 cells in a dose-dependent fashion, dose-dependently inhibits the IFN-gamma-stimulated phosphorylation of p38 MAPK with IC50 of 290 nM; inhibits TNF production, attenuates carrageenan-induced paw inflammation in mice.Asthma Phase 2 Clinical
-
同义词SB95952;ZK62711;(R,S)-Rolipram;SB 95952;ZK 62711;SB-95952;ZK-62711
-
通路Angiogenesis
-
靶点PDE
-
受体PDE4B;PDE4D
-
研究领域Inflammation/Immunology
-
适应症Asthma
化学信息
-
CAS Number61413-54-5
-
分子量275.34
-
分子式C16H21NO3
-
纯度>98% (HPLC)
-
溶解度DMSO: ≥ 41 mg/mL
-
SMILESO=C1NCC(C2=CC=C(OC)C(OC3CCCC3)=C2)C1
-
化学全称2-Pyrrolidinone, 4-[3-(cyclopentyloxy)-4-methoxyphenyl]-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. MacKenzie SJ, et al. Biochem J. 2000 Apr 15;347(Pt 2):571-8.
2. Korhonen R, et al. Br J Pharmacol. 2013 Aug;169(7):1525-36.
3. Shalaby AM, et al. J Pharmacol Pharmacother. 2012 Apr;3(2):132-7.
2. Korhonen R, et al. Br J Pharmacol. 2013 Aug;169(7):1525-36.
3. Shalaby AM, et al. J Pharmacol Pharmacother. 2012 Apr;3(2):132-7.
产品手册
关联产品
-
Siguazodan
Siguazodan is an effective, selective, orally active phosphodiesterase III ((PDE-III)) inhibitor with an IC50 of 117 nM.
-
LJI308
LJI308 is a potent, and pan-RSK (p90 ribosomal S6 kinase) inhibitor with IC50 of 6 nM, 4 nM, and 13 nM for RSK1, RSK2, and RSK3, respectively.
-
Aminophylline
Aminophylline is a competitive nonselective phosphodiesterase inhibitor that is used to treat airway obstruction from asthma or COPD.